![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Abl2 | Mouse | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ABL2 mRNA | CTD | PMID:22079256 | Abl2 | Mouse | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of ABL2 mRNA | CTD | PMID:26682919 | Abl2 | Mouse | 17beta-estradiol | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of ABL2 mRNA | CTD | PMID:30165855 | Abl2 | Mouse | 17beta-estradiol | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of ABL2 mRNA | CTD | PMID:31614463 | Abl2 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ABL2 mRNA | CTD | PMID:21296121 | Abl2 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | ABL2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ABL2 mRNA | CTD | PMID:22298810 | Abl2 | Mouse | 2-hydroxypropanoic acid | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of ABL2 mRNA | CTD | PMID:30851411 | Abl2 | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA | CTD | PMID:28628672 | Abl2 | Mouse | 4,4'-sulfonyldiphenol | decreases expression | EXP | | 6480464 | bisphenol S results in decreased expression of ABL2 mRNA | CTD | PMID:39298647 | Abl2 | Mouse | acrolein | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ABL2 mRNA | CTD | PMID:32699268 | Abl2 | Mouse | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of ABL2 mRNA | CTD | PMID:19770486 | Abl2 | Mouse | aflatoxin B1 | increases methylation | ISO | ABL2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of ABL2 intron | CTD | PMID:30157460 | Abl2 | Mouse | alpha-pinene | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ABL2 mRNA | CTD | PMID:32699268 | Abl2 | Mouse | aristolochic acid A | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of ABL2 mRNA | CTD | PMID:33212167 | Abl2 | Mouse | arsane | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA | CTD | PMID:32525701 | Abl2 | Mouse | arsenic atom | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA | CTD | PMID:32525701 | Abl2 | Mouse | arsenite(3-) | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ABL2 mRNA] | CTD | PMID:32406909 | Abl2 | Mouse | benzo[a]pyrene | increases methylation | ISO | ABL2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ABL2 promoter | CTD | PMID:27901495 | Abl2 | Mouse | benzo[a]pyrene | decreases methylation | ISO | ABL2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ABL2 3' UTR | CTD | PMID:27901495 | Abl2 | Mouse | benzo[a]pyrene | affects methylation | ISO | ABL2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ABL2 intron | CTD | PMID:30157460 | Abl2 | Mouse | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ABL2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | Abl2 | Mouse | benzo[e]pyrene | increases methylation | ISO | ABL2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of ABL2 intron | CTD | PMID:30157460 | Abl2 | Mouse | bisphenol A | affects expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ABL2 mRNA | CTD | PMID:25181051 | Abl2 | Mouse | bisphenol A | increases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ABL2 mRNA | CTD | PMID:34947998 | Abl2 | Mouse | bisphenol A | decreases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ABL2 mRNA | CTD | PMID:30816183 and PMID:32528016 | Abl2 | Mouse | bisphenol F | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA | CTD | PMID:28628672 | Abl2 | Mouse | boron nitride | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | boron nitride results in increased expression of ABL2 mRNA | CTD | PMID:30644070 | Abl2 | Mouse | butanal | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of ABL2 mRNA | CTD | PMID:26079696 | Abl2 | Mouse | C60 fullerene | decreases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of ABL2 mRNA | CTD | PMID:19167457 | Abl2 | Mouse | cadmium atom | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Cadmium results in increased expression of ABL2 mRNA | CTD | PMID:21120746 | Abl2 | Mouse | cadmium dichloride | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of ABL2 mRNA | CTD | PMID:38568856 | Abl2 | Mouse | cadmium sulfate | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | cadmium sulfate results in increased expression of ABL2 mRNA | CTD | PMID:12064557 and PMID:14676411 | Abl2 | Mouse | caffeine | decreases phosphorylation | ISO | ABL2 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of ABL2 protein | CTD | PMID:35688186 | Abl2 | Mouse | cannabidiol | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [Dronabinol co-treated with Cannabidiol] results in increased expression of ABL2 mRNA | CTD | PMID:26504004 | Abl2 | Mouse | carbamazepine | affects expression | ISO | ABL2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ABL2 mRNA | CTD | PMID:24752500 | Abl2 | Mouse | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of ABL2 mRNA | CTD | PMID:37019170 | Abl2 | Mouse | cisplatin | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of ABL2 mRNA | CTD | PMID:27392435 | Abl2 | Mouse | copper atom | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ABL2 mRNA | CTD | PMID:20971185 | Abl2 | Mouse | copper(0) | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ABL2 mRNA | CTD | PMID:20971185 | Abl2 | Mouse | copper(II) sulfate | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ABL2 mRNA | CTD | PMID:19549813 | Abl2 | Mouse | coumarin | affects phosphorylation | ISO | ABL2 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of ABL2 protein | CTD | PMID:35688186 | Abl2 | Mouse | crocidolite asbestos | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in increased expression of ABL2 mRNA | CTD | PMID:18687144 and PMID:25351596 | Abl2 | Mouse | crocidolite asbestos | affects expression | ISO | ABL2 (Homo sapiens) | 6480464 | Asbestos and Crocidolite affects the expression of ABL2 mRNA | CTD | PMID:25757056 | Abl2 | Mouse | cyclosporin A | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ABL2 mRNA | CTD | PMID:20106945 | Abl2 | Mouse | dexamethasone | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA | CTD | PMID:28628672 | Abl2 | Mouse | Dibutyl phosphate | affects expression | ISO | ABL2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ABL2 mRNA | CTD | PMID:37042841 | Abl2 | Mouse | diclofenac | affects expression | ISO | ABL2 (Homo sapiens) | 6480464 | Diclofenac affects the expression of ABL2 mRNA | CTD | PMID:24752500 | Abl2 | Mouse | dopamine | decreases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | Dopamine results in decreased expression of ABL2 mRNA | CTD | PMID:21983523 | Abl2 | Mouse | dorsomorphin | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA | CTD | PMID:27188386 | Abl2 | Mouse | doxorubicin | decreases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ABL2 mRNA | CTD | PMID:29803840 | Abl2 | Mouse | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of ABL2 mRNA | CTD | PMID:30319688 | Abl2 | Mouse | fenoldopam | increases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | Fenoldopam results in increased expression of ABL2 mRNA | CTD | PMID:21983523 | Abl2 | Mouse | fluoranthene | multiple interactions | EXP | | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABL2 mRNA | CTD | PMID:28329830 | Abl2 | Mouse | FR900359 | decreases phosphorylation | ISO | ABL2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of ABL2 protein | CTD | PMID:37730182 | Abl2 | Mouse | gentamycin | increases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of ABL2 mRNA | CTD | PMID:33387578 | Abl2 | Mouse | hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | Abl2 | Mouse | indometacin | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA | CTD | PMID:28628672 | Abl2 | Mouse | lead(0) | decreases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Lead results in decreased expression of ABL2 mRNA | CTD | PMID:19921347 | Abl2 | Mouse | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with IL4] results in increased expression of ABL2 mRNA and Lipopolysaccharides affects the reaction [IL4 protein results in increased expression of ABL2 mRNA] | CTD | PMID:22024136 | Abl2 | Mouse | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of ABL2 mRNA | CTD | PMID:22024136 | Abl2 | Mouse | methapyrilene | increases methylation | ISO | ABL2 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of ABL2 intron | CTD | PMID:30157460 | Abl2 | Mouse | methylisothiazolinone | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of ABL2 mRNA | CTD | PMID:31629900 | Abl2 | Mouse | N,N-diethyl-m-toluamide | multiple interactions | ISO | Abl2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of ABL2 gene | CTD | PMID:33148267 | Abl2 | Mouse | nickel atom | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Nickel results in increased expression of ABL2 mRNA | CTD | PMID:24768652 and PMID:25583101 | Abl2 | Mouse | ozone | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA more ... | CTD | PMID:32699268 | Abl2 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ABL2 mRNA | CTD | PMID:27106289 | Abl2 | Mouse | paracetamol | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ABL2 mRNA | CTD | PMID:29067470 | Abl2 | Mouse | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ABL2 mRNA | CTD | PMID:37995155 | Abl2 | Mouse | perfluorononanoic acid | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of ABL2 mRNA | CTD | PMID:32588087 | Abl2 | Mouse | permethrin | multiple interactions | ISO | Abl2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of ABL2 gene | CTD | PMID:33148267 | Abl2 | Mouse | phenobarbital | affects expression | ISO | ABL2 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of ABL2 mRNA | CTD | PMID:19159669 | Abl2 | Mouse | phenylmercury acetate | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA | CTD | PMID:27188386 | Abl2 | Mouse | ponatinib | decreases activity | ISO | ABL2 (Homo sapiens) | 6480464 | ponatinib results in decreased activity of ABL2 protein | CTD | PMID:19878872 | Abl2 | Mouse | potassium chromate | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ABL2 mRNA | CTD | PMID:22079256 | Abl2 | Mouse | potassium chromate | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of ABL2 mRNA | CTD | PMID:22079256 | Abl2 | Mouse | potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of ABL2 mRNA | CTD | PMID:23608068 | Abl2 | Mouse | rac-lactic acid | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of ABL2 mRNA | CTD | PMID:30851411 | Abl2 | Mouse | SB 431542 | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA | CTD | PMID:27188386 | Abl2 | Mouse | silicon dioxide | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of ABL2 mRNA and Silicon Dioxide results in increased expression of ABL2 mRNA | CTD | PMID:25351596 and PMID:25895662 | Abl2 | Mouse | sodium arsenate | multiple interactions | ISO | ABL2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA | CTD | PMID:32525701 | Abl2 | Mouse | sodium arsenate | decreases expression | EXP | | 6480464 | sodium arsenate results in decreased expression of ABL2 mRNA | CTD | PMID:21795629 | Abl2 | Mouse | sodium arsenite | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ABL2 mRNA | CTD | PMID:12760830 and PMID:38568856 | Abl2 | Mouse | sodium arsenite | decreases expression | ISO | ABL2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ABL2 mRNA | CTD | PMID:29301061 | Abl2 | Mouse | taurine | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Taurine results in increased expression of ABL2 mRNA | CTD | PMID:16579726 | Abl2 | Mouse | testosterone | decreases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of ABL2 mRNA | CTD | PMID:33359661 | Abl2 | Mouse | theophylline | decreases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Theophylline results in decreased expression of ABL2 mRNA | CTD | PMID:16083514 | Abl2 | Mouse | thioacetamide | increases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ABL2 mRNA | CTD | PMID:34492290 | Abl2 | Mouse | thiram | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Thiram results in increased expression of ABL2 mRNA | CTD | PMID:38568856 | Abl2 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of ABL2 promoter | CTD | PMID:35295148 | Abl2 | Mouse | triphenyl phosphate | affects expression | ISO | ABL2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ABL2 mRNA | CTD | PMID:37042841 | Abl2 | Mouse | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of ABL2 mRNA | CTD | PMID:30912803 | Abl2 | Mouse | valproic acid | decreases expression | ISO | Abl2 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of ABL2 mRNA | CTD | PMID:29427782 | Abl2 | Mouse | valproic acid | affects splicing | ISO | Abl2 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of ABL2 mRNA | CTD | PMID:29427782 | Abl2 | Mouse | xylitol | increases expression | ISO | ABL2 (Homo sapiens) | 6480464 | Xylitol results in increased expression of ABL2 mRNA | CTD | PMID:32275922 | |